New hope for MOGAD patients: drug aims to stop relapses
NCT ID NCT06452537
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times
Summary
This study tests whether tocilizumab can safely prevent relapses in people with MOGAD, a rare autoimmune disease that attacks the nervous system. About 102 participants aged 12 and older with recent relapses will receive the drug or a placebo. The main goal is to see if the drug delays the next relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221006, China
-
Anhui Provincial Hospital
Hefei, Anhui, 230001, China
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, 100000, China
-
Children's Hospital of Soochow University
Suzhou, Jiangsu, 215025, China
-
China-Japan Friendship Hospital
Beijing, 100000, China
-
Chinese PLA General Hospital
Beijing, 100000, China
-
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030000, China
-
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 751705, China
-
Hebei Children's Hospital
Shijiazhuang, Hebei, 050000, China
-
Huashan Hospital, Fudan University
Shanghai, 200000, China
-
Ordos Central Hospital
Ordos, Inner Mongolia, 017000, China
-
People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang Uygur Autonomous Region, 830001, China
-
The First Affiliated Hospital of Tsinghua University
Beijing, 100000, China
-
The First Affiliated Hospital of Zhengzhou University
Zhenzhou, Henan, China
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150086, China
-
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
-
The Second Hospital of Lanzhou University
Lanzhou, Gansu, 73000, China
-
The Third Affiliated Hospital of Soochow University
Changzhou, Jiangsu, 213000, China
-
Tianjin Children's Hospital
Tianjin, 30052, China
-
Tianjin Huanhu Hospital
Tianjin, 300052, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
-
XuanWu Hospital Capital Medical University
Beijing, 100000, China
Conditions
Explore the condition pages connected to this study.